Enhancement of adriamycin-induced mortality during riboflavin administration and riboflavin deficiency in rats Journal Article


Authors: Raiczyk, G. B.; Rivlin, R. S.; Pinto, J.
Article Title: Enhancement of adriamycin-induced mortality during riboflavin administration and riboflavin deficiency in rats
Abstract: Adriamycin-treated rats were monitored for survivorship while consuming a normal diet adequate in riboflavin, a normal diet and receiving daily high-dose injections of riboflavin-5'-phosphate (flavin mononucleotide, FMN), or a riboflavin-deficient diet. Each animal was compared to a corresponding pair-fed, saline-treated control. In adriamycin-treated rats fed the normal chow diet alone, survivorship declined within 7 days and remained constant after 12 days to about 50%. Adriamycin-treated rats consuming the normal diet and injected with FMN initially showed similar survivorship; however, after 20 days survival fell to 14%. Adriamycin-treated, riboflavin-deficient rats showed within 5 days a precipitous decline in survivorship which leveled to 5%. These results suggest that during adriamycin treatment, proper riboflavin nutriture may be a crucial determinant of survival.
Keywords: mortality; doxorubicin; drug efficacy; nonhuman; methodology; animal experiment; animal model; animalia; rat; short survey; intravenous drug administration; oral drug administration; drug indication; etiology; intraperitoneal drug administration; priority journal; riboflavin
Journal Title: Proceedings of the Society for Experimental Biology and Medicine
Volume: 188
Issue: 4
ISSN: 0037-9727
Publisher: Blackwell Publishing  
Date Published: 1988-01-01
Start Page: 495
End Page: 499
Language: English
DOI: 10.3181/00379727-188-42767
PUBMED: 3420113
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 6 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John   Pinto
    59 Pinto
  2. Richard S Rivlin
    67 Rivlin